gms | German Medical Science

57th Annual Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN)

German Society for Neuropathology and Neuroanatomy

12. - 15.09.2012, Erlangen

Poster Presentations

Meeting Abstract (12dgnnPP3.1)

Tumor epigenetics: 5-Hydroxymethylcytosine in the human glioblastoma

Kraus T, Widmann D, Greiner A, Kolck G, Eigenbrod S, Globisch D, Wagner M, Carell T, Kretzschmar H
[Full Text]
Meeting Abstract (12dgnnPP3.2)

Frequent down-regulation of bone morphogenetic protein (BMP) genes 2, 4 and 6 in murine and human medulloblastomas

Zipper P, Grünheck F, Reifenberger G
[Full Text]
Meeting Abstract (12dgnnPP3.3)

Constitutive activation of Wnt signaling in neural progenitors results in disrupted proliferation and migration of neurons within in the cerebral and cerebellar cortex

Pöschl J, Grammel D, Dorostkar M, Kretzschmar H, Schüller U
[Full Text]
Meeting Abstract (12dgnnPP3.4)

17-beta Estradiol increases Connexin43 expression on F-98 rat glioma cell line

Moinfar Z, Seval Ismail F, Dambach H, Hinkerohe D, Gold R, Faustmann PM
[Full Text]
Meeting Abstract (12dgnnPP3.5)

Potential Role of Epithelial to Mesenchymal Transition in Meningioma

Wallesch M, Kirches E, Mawrin C
[Full Text]
Meeting Abstract (12dgnnPP3.6)

ZEB1 mediates invasion and chemoresistance of glioblastoma

Siebzehnrubl F, Silver D, Tugertimur B, Deleyrolle L, Suslov O, Siebzehnrubl D, Sarkisian M, Devers K, Yachnis A, Kuepper M, Nabilsi N, Kladde M, Brabletz S, Brabletz T, Reynolds B, Steindler D
[Full Text]
Meeting Abstract (12dgnnPP3.7)

miR-328 promotes glioma cell invasion via SFRP1-dependent WNT-signaling activation

Delic S, Lottmann N, Liesenberg F, Wolter M, Götze S, Zapatka M, Reifenberger G, Riemenschneider MJ
[Full Text]
Meeting Abstract (12dgnnPP3.8)

Detection of meningeosis carcinomatosa micro-cell-clusters after surgery of an acute subdural haematoma – a case report

Brand C, Gundelach T, Scheuerle A, Wirtz CR, Kapapa T
[Full Text]
Meeting Abstract (12dgnnPP3.9)

DNA damage and repair in glioblastoma cell lines after antitumor drugs

Annovazzi L, Caldera V, Mellai M, Piazzi A, Monzeglio O, Schiffer D
[Full Text]
Meeting Abstract (12dgnnPP3.10)

Targeting mTORC1 is an effective strategy to inhibit meningioma cell tumorigenicity

Pachow D, Kirches E, Mawrin C
[Full Text]
Meeting Abstract (12dgnnPP3.11)

Expression of SWI/SNF-subunit BAF170 (BRG1-associated factor 170) in peripheral and vestibular schwannomas

Stahn V, Wesemann M, Fischer S, Senner V, Peetz-Dienhard S, Masla M, Harder A
[Full Text]
Meeting Abstract (12dgnnPP3.12)

Phenotypes of NF1 associated Peripheral Nerve Sheath Tumors are associated with modified Retinoic acid signaling mediated by differential CRABPII expression

Fischer S, Dombrowski A, Wilke G, Mautner VF, Friedrich RE, Heppner F, Harder A
[Full Text]
Meeting Abstract (12dgnnPP3.13)

Association of neuroepithelial tumours and microscopic focal cortical dysplasias in patients with drug-resistant temporal lobe epilepsy.

Estupiñán Díaz BO, Morales Chacón LM, García Maeso I, Báez Martín MM, Lorigados Pedre L, Trápaga Quincoses O, Hidalgo Portal L, Gómez Lotti A
[Full Text]
Meeting Abstract (12dgnnPP3.14)

Far Upstream Element [FUSE] Binding Protein 1 (FUBP1) expression is associated with increased proliferative activity, p53 accumulation and the presence of mutations in human gliomas

Baumgarten P, Harter PN, Tönjes M, Capper D, Blank AE, Schwamb B, Rabenhorst U, Kögel D, Rieker RJ, Plate KH, Ohgaki H, Radlwimmer B, Zörnig M, Mittelbronn M
[Full Text]
Meeting Abstract (12dgnnPP3.15)

Cytomegalovirus infection as potential factor in CNS tumor development and progression

Baumgarten P, Michaelis M, Rothweiler F, Berger A, Allwin R, Starzetz T, Harter PN, Doerr HW, Cinatl jr. J, Mittelbronn M
[Full Text]
Meeting Abstract (12dgnnPP3.16)

Haemangioblastoma: series of 24 cases with clinicopathological features

Epari S, Bhatkar R, Moyaidi A, Shetty P, Gupta T, Kane S, Jalali R
[Full Text]
Meeting Abstract (12dgnnPP3.17)

DNT-like malformation and further neuropathological findings in a patient with Robinow syndrome

Romeike BFM, Diab M, Petersen I
[Full Text]
Meeting Abstract (12dgnnPP3.18)

Functional activation of the Wnt signalling pathway in medulloblastoma cell lines.

Bradtmöller M, Guse K, Stenzel W, Ulrich T, Heppner F, Koch A
[Full Text]
Meeting Abstract (12dgnnPP3.19)

Association of TET1 nuclear exclusion with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas

Müller T, Gessi M, Waha A, Isselstein LJ, Luxen D, Freihoff D, Freihoff J, Becker A, Simon M, Hammes J, Denkhaus D, zur Mühlen A, Pietsch T, Waha A
[Full Text]
Meeting Abstract (12dgnnPP3.20)

Molecular analysis of MTSS1 in gliomas

Luxen D, Gessi M, Isselstein LJ, Müller T, Freihoff D, Freihoff J, Simon M, Pietsch T, Waha A, Waha A
[Full Text]
Meeting Abstract (12dgnnPP3.21)

Hybrid neurofibroma / schwannoma – a molecular study

Wesemann M, Nagel I, Fischer S, Stahn V, Gesk S, Oyen F, Schneppenheim R, Siebert R, Paulus W, Harder A
[Full Text]
Meeting Abstract (12dgnnPP3.22)

Spinal pilomyxoid astrocytoma developing a LOH 1p19q and cerebral metastasis

Eigenbrod S, Thon N, Jansen N, Janssen H, Mielke J, Ruiter M, la Fougère C, Peraud A, Egensperger R, Kretzschmar H
[Full Text]
Meeting Abstract (12dgnnPP3.23)

Dissecting the chemokine-driven spread of B cell lymphoma cells into the central nervous system

Wagner L, Gül E, Kälin RE, Prokop S, Wilke G, Heppner FL
[Full Text]
Meeting Abstract (12dgnnPP3.24)

MAPK pathway activation by GNAQ and GNA11 mutations in melanocytic tumors of the central nervous system.

Gessi M, Hammes J, Lauriola L, Dörner E, Kirfel J, Kristiansen G, zur Muehlen A, Denkhaus D, Waha A, Pietsch T
[Full Text]
Meeting Abstract (12dgnnPP3.25)

KIAA1549-BRAF fusion status in rosette-forming glioneuronal tumors of the fourth ventricle (RGNT)

Gessi M, Lambert S, Lauriola L, Waha A, Collins VP, Pietsch T
[Full Text]
Meeting Abstract (12dgnnPP3.26)

A pyrosequencing based identification of histone H3.3 K27M mutations: a diagnostic tool inbrain tumors ofchildhood?

Gielen GH, Gessi M, Hammes J, Kramm CM, Waha A, Pietsch T
[Full Text]
Meeting Abstract (12dgnnPP3.27)

Molecular analysis of Gremlin in gliomas

Isselstein LJ, Gessi M, Müller T, Luxen D, Freihoff D, Freihoff J, Scheffler B, Simon M, Pietsch T, Waha A, Waha A
[Full Text]
Meeting Abstract (12dgnnPP3.28)

Rhabdomyoma of the Internal Auditory Canal – Case Report

Rizk A, Ebner F, Schuhmann M, Tatagiba M
[Full Text]
Meeting Abstract (12dgnnPP3.29)

CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas

Sahm F, Koelsche C, Meyer J, Pusch S, Lindenberg K, Mueller W, Herold-Mende C, von Deimling A, Hartmann C
[Full Text]
Meeting Abstract (12dgnnPP3.30)

BRAF V600E immunohistochemistry in the diagnosis of Pleomorphic xanthoastrocyomas and Gangliogliomas

Kölsche C, Schittenhelm J, Wöhrer A, Jeibmann A, Kohlhof P, Preusser M, von Deimling A, Capper D
[Full Text]
Meeting Abstract (12dgnnPP3.31)

Expression patterns of EGFR-, PDGFR- and VEGFR –IHC in recurrent WHO grade III meningiomas

Geiger K, Juratli T, Mierke C, Kirsch M, Meinhardt M, Schackert G
[Full Text]
Meeting Abstract (12dgnnPP3.32)

Intraoperative Alanin and histopathology are unable to demonstrate a recurrent glioblastoma, positively identified by FET PET-CT

Woischneck D, Permanetter W, Feiden W, Blumstein N
[Full Text]
Meeting Abstract (12dgnnPP3.33)

Immunohistochemical analysis of cancer stem cell markers CD44 and CD133 in craniopharyngiomas

Hölsken A, Stache C, Fahlbusch R, Buchfelder M, Buslei R
[Full Text]